Finance

Lists
ALVO:NASDAQ
Alvotech SA
$5.87
+9.93%
(+0.53) 1D
$5.95
+1.36% (+0.080)
After hours
Closed: Sep 18, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALVO...
Open
$5.40
High
$5.98
Low
$5.40
Mkt. cap
2.09B
Avg. vol.
1.04M
Volume
3.54M
52-wk high
$9.25
52-wk low
$2.94
EPS
-$0.63
Beta
0.22
Shares outstanding
390.43M
No. of employees
1K
Open
$5.40
High
$5.98
Low
$5.40
Mkt. cap
2.09B
Avg. vol.
1.04M
Volume
3.54M
52-wk high
$9.25
52-wk low
$2.94
EPS
-$0.63
Beta
0.22
Shares outstanding
390.43M
No. of employees
1K
News stories
From web sources and news partners
About Alvotech SA
CEO-
Employees1.28K
Founded2013
Headquarters-
SectorBiotechnology
Websitealvotech.com
Analyst ratings
Based on 3 analysts giving stock ratings to ALVO in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for ALVO in the last 3 months.
Highest
Current $5.87
$8.00 (+36.29%)
Average
$7.00 (+19.25%)
Lowest
$6.00 (+2.21%)
Analyst
Recommendation
Action
Price target
Projected
Date
Glen Santangelo
Barclays
Buy
Upgraded
$8.00
+36.3%
09/16/2026
Jason Gerberry
Bank of America Securities
Buy
Initiated
$7.00
+19.3%
08/24/2026
Ashwani Verma
UBS
Buy
Reiterated
$6.00
+2.2%
08/24/2026
Niall Alexander
Deutsche Bank
Hold
Maintained
$4.00
-31.9%
03/24/2026
Jenna Davidner
Barclays
Sell
Reiterated
$4.00
-31.9%
03/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
113.86M
168.90M
105.94M
105.91M
Cost of goods sold
35.01M
61.28M
46.09M
52.20M
Cost of revenue
35.01M
61.28M
46.09M
52.20M
Research and development expenses
60.42M
30.88M
24.51M
21.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
21.42M
19.58M
25.67M
43.56M
Operating expense
81.84M
50.46M
50.18M
65.41M
Total operating expenses
116.85M
111.74M
96.27M
117.61M
Operating income
-2.99M
57.16M
9.67M
-11.70M
Other non operating income
20.28M
24.35M
32.23M
-16.92M
EBT including unusual items
-6.09M
39.70M
986.00K
-66.76M
EBT excluding unusual items
-18.58M
47.84M
986.00K
-66.76M
Income tax expense
-835.00K
148.25M
-44.00K
59.00K
Effective tax rate
13.72%
373.39%
-4.46%
-0.09%
Other operating expenses
-
-
-
-
Net income
-5.25M
-108.55M
1.03M
-66.82M
Net profit margin
-4.61%
-64.27%
0.97%
-63.09%
Earnings per share
-0.11
0.01
-0.09
-0.11
Interest and investment income
1.93M
-
1.18M
508.00K
Interest expense
-36.26M
-38.05M
-40.81M
-41.02M
Net interest expenses
-34.33M
-38.05M
-39.62M
-40.52M
Depreciation and amortization charges
-
-
-
-
EBITDA
13.87M
67.57M
16.18M
-5.20M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps